IFIT2 Depletion Promotes Cancer Stem Cell-like Phenotypes in Oral Cancer.
Kuo-Chu LaiPrabha RegmiChung-Ji LiuJeng-Fan LoTe-Chang LeePublished in: Biomedicines (2023)
(1) Background: Cancer stem cells (CSCs) are a small cell population associated with chemoresistance, metastasis and increased mortality rate in oral cancer. Interferon-induced proteins with tetratricopeptide repeats 2 (IFIT2) depletion results in epithelial to mesenchymal transition, invasion, metastasis, and chemoresistance in oral cancer. To date, no study has demonstrated the effect of IFIT2 depletion on the CSC-like phenotype in oral cancer cells. (2) Methods: Q-PCR, sphere formation, Hoechst 33,342 dye exclusion, immunofluorescence staining, and flow cytometry assays were performed to evaluate the expression of the CSC markers in IFIT2-depleted cells. A tumorigenicity assay was adopted to assess the tumor formation ability. Immunohistochemical staining was used to examine the protein levels of IFIT2 and CD24 in oral cancer patients. (3) Results: The cultured IFIT2 knockdown cells exhibited an overexpression of ABCG2 and CD44 and a downregulation of CD24 and gave rise to CSC-like phenotypes. Clinically, there was a positive correlation between IFIT2 and CD24 in the patients. IFIT2 high /CD24 high /CD44 low expression profiles predicted a better prognosis in HNC, including oral cancer. The TNF-α blockade abolished the IFIT2 depletion-induced sphere formation, indicating that TNF-α may be involved in the CSC-like phenotypes in oral cancer. (4) Conclusions: The present study demonstrates that IFIT2 depletion promotes CSC-like phenotypes in oral cancer.
Keyphrases
- cancer stem cells
- flow cytometry
- induced apoptosis
- rheumatoid arthritis
- end stage renal disease
- nk cells
- stem cells
- high throughput
- type diabetes
- signaling pathway
- cell cycle arrest
- chronic kidney disease
- poor prognosis
- single cell
- prognostic factors
- drug induced
- cardiovascular disease
- diabetic rats
- cell therapy
- ejection fraction
- patient reported outcomes
- small molecule
- mesenchymal stem cells
- protein protein